
Neutrogena is owned by Kenvue (NYSE: KENV), which was spun off from Johnson & Johnson in 2023. J&J acquired Neutrogena in 1994. In November 2025, Kimberly-Clark announced an agreement to acquire Kenvue for approximately $48.7 billion, with the deal expected to close in the second half of 2026. Neutrogena is headquartered in Los Angeles, California, USA, and is sold in over 70 countries.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Neutrogena | Kenvue | Wholly owned |
Neutrogena was founded in 1930 by Emanuel Stolaroff as a cosmetics company called Natone. Initially, Stolaroff's business focused on distributing cosmetic products to beauty salons and department stores throughout California. The company operated as a cosmetics distributor until 1954, when Stolaroff acquired the rights to a transparent soap formula developed by Belgian chemist Edmond Fromont.
The soap was different from traditional soaps because it did not leave the filmy residue that conventional soaps left on the skin. Stolaroff renamed the product "Neutrogena" and it became the company's flagship product. The soap's success was significant enough that Stolaroff changed the company's name to Neutrogena Corporation and shifted focus to developing dermatologist-recommended skincare products.
Throughout the 1960s and 1970s, Neutrogena expanded its product line with skincare solutions developed in consultation with dermatologists. The company built relationships with the medical community and established itself as a scientifically-backed skincare brand. In 1987, Neutrogena introduced the Norwegian Formula hand cream, which became another iconic product in the company's portfolio.
Johnson & Johnson acquired Neutrogena in 1994 for approximately $1.2 billion. Under J&J ownership, Neutrogena expanded its product range significantly, adding acne treatments, anti-aging products, sun protection lines, and body care products. The brand became a fixture in drugstores, mass retailers, and supermarkets across the United States and internationally.
In May 2023, Johnson & Johnson spun off its consumer health division as Kenvue, and Neutrogena became part of the newly independent company. Under Kenvue ownership, Neutrogena has continued to focus on scientific innovation and clinical testing while expanding into new skincare categories. The brand has faced headwinds in 2025 and 2026 as Kenvue's skincare segment experienced declining sales, partly attributed to competition from CeraVe and other dermatological brands.
The pending acquisition by Kimberly-Clark, announced in November 2025, represents a significant shift for Neutrogena. If the deal closes as expected in H2 2026, Neutrogena would move from a pure consumer health company to a combined personal care and consumer health conglomerate.
Who owns Kenvue?
Kenvue is a publicly traded company listed on the New York Stock Exchange under the ticker KVUE. No single shareholder holds a controlling stake. Institutional investors hold the majority of shares. Johnson & Johnson fully divested its Kenvue shares in August 2023 through an exchange offer. Upon completion of the Kimberly-Clark acquisition, expected in Q4 2026, Kenvue will become a wholly owned subsidiary of Kimberly-Clark Corporation.
Is Kenvue being acquired?
Yes. On November 2, 2025, Kimberly-Clark announced a definitive merger agreement to acquire Kenvue for approximately $48.7 billion in cash and stock. Shareholders of both companies approved the transaction on January 29, 2026. The HSR waiting period expired on February 4, 2026. The transaction is expected to close in Q4 2026, subject to foreign regulatory approvals.
What is Kenvue's revenue?
Kenvue reported FY2025 net sales of $15.1 billion, down 2.1% from $15.5 billion in FY2024. FY2025 net income was $1.47 billion, with diluted EPS of $0.76 and adjusted diluted EPS of $1.08. In Q1 2026, net sales grew 3.2% and organic sales grew 1.2%. In Q2 2026, the company reported its third consecutive quarter of growth across all segments and regions.
Who is the CEO of Kenvue?
Kirk Perry serves as CEO of Kenvue. He was named interim CEO in early 2025 following the termination of previous CEO Thibaut Mongon, and was named permanent CEO in November 2025. Under Perry's leadership, Kenvue has delivered three consecutive quarters of net and organic sales growth and is executing a 2026 Restructuring Initiative targeting $250 million in pre-tax charges for supply chain optimization.
Is Kenvue still publicly traded?
Yes, Kenvue continues to trade on the New York Stock Exchange under the ticker KVUE as of August 2026. Upon completion of the Kimberly-Clark acquisition, expected in Q4 2026, Kenvue shares will be delisted as the company becomes a wholly owned subsidiary of Kimberly-Clark.
When was Kenvue founded?
Kenvue was spun off from Johnson & Johnson in May 2023 via an IPO that raised $3.8 billion. J&J completed the full separation in August 2023 through an exchange offer. The company was created to operate independently as a focused consumer health company, allowing J&J to concentrate on its pharmaceutical and medical device businesses.
What brands does Kenvue own?
Kenvue owns Tylenol, Listerine, Band-Aid, Neutrogena, Aveeno, Zyrtec, Johnson's, Motrin, Benadryl, Sudafed, Pepcid, Imodium, Nicorette, Visine, and Calpol. These brands hold number-one or number-two market positions in their respective categories.
Where is Kenvue headquartered?
Kenvue is headquartered in Summit, New Jersey, USA. The company relocated from Skillman, New Jersey, where it was initially based following the spin-off from Johnson & Johnson. Kenvue is incorporated in Delaware and maintains manufacturing facilities, research and development centers, and distribution networks across the United States, Europe, Asia, and Latin America.
What is the Kimberly-Clark Kenvue merger?
The Kimberly-Clark Kenvue merger is a pending acquisition announced on November 2, 2025, under which Kimberly-Clark will acquire all outstanding Kenvue shares in a cash and stock transaction valued at approximately $48.7 billion enterprise value. The combined company would generate approximately $32 billion in annual revenue and $7 billion in adjusted EBITDA. Kimberly-Clark identified $1.9 billion in cost synergies and $500 million in revenue synergies. The transaction is expected to close in Q4 2026.
Neutrogena operates under Kenvue's sustainability framework, focusing on responsible ingredient sourcing, sustainable packaging, environmental impact reduction, and ethical business practices.
Sustainable Packaging: Neutrogena has made progress in incorporating recycled materials into its packaging and reducing plastic waste. The brand participates in recycling programs and has initiatives to increase the recyclability of its bottles and containers. Kenvue has committed to making all packaging recyclable, reusable, or compostable by 2030 where infrastructure allows.
Responsible Ingredients: Neutrogena formulations use scientifically-backed ingredients with strict safety standards. The brand maintains ingredient transparency and works with suppliers who follow sustainable sourcing practices for raw materials while maintaining clinical efficacy.
Water Conservation: Kenvue has implemented water reduction initiatives across its manufacturing facilities, including those producing Neutrogena products. The company focuses on water efficiency in production processes and has set targets for reducing water usage per unit of production.
Ethical Sourcing: Neutrogena sources ingredients from suppliers who adhere to ethical labor practices and environmental standards. The brand maintains supply chain transparency and works with partners who share Kenvue's commitment to social responsibility and environmental stewardship.
Neutrogena has received recognition primarily for product efficacy and dermatologist recommendations rather than environmental or ethical achievements. The brand consistently ranks among dermatologists' top recommended skincare products, particularly for acne treatment and sun protection. Neutrogena's Hydro Boost line has received beauty industry awards for hydration technology, and the brand's sunscreen products carry the Skin Cancer Foundation's Seal of Recommendation.
The brand's marketing campaigns have earned recognition from consumer beauty publications for effective communication of scientific skincare benefits. Neutrogena's partnership with dermatologists and medical professionals has been acknowledged as an effective strategy for building consumer trust and credibility in the competitive skincare market.
Neutrogena has not received significant recognition for sustainability initiatives or ethical business practices. The brand's lack of cruelty-free certification and ongoing animal testing concerns have prevented it from receiving awards from ethical consumer organizations. Product safety recalls have also impacted the brand's reputation in corporate responsibility categories.
Benzene Contamination Recall (July 2021): Johnson & Johnson voluntarily recalled all lots of five Neutrogena aerosol sunscreen products after internal testing identified low levels of benzene, a known human carcinogen. The recalled products included Beach Defense, Cool Dry Sport, Invisible Daily Defense, and Ultra Sheer aerosol sunscreens. While benzene was not an ingredient in the products, contamination was detected in finished products, leading to a nationwide recall and consumer safety concerns about aerosol sunscreen manufacturing processes.
Parent Company Talc Litigation: Neutrogena's former parent company Johnson & Johnson faced significant legal challenges related to talc-based products, with juries ordering the company to pay damages to plaintiffs who alleged baby powder caused their ovarian cancer. While Neutrogena products were not directly involved and the brand is now owned by Kenvue, this litigation impacted consumer trust across the broader J&J consumer health portfolio.
Animal Testing Controversy: Neutrogena faces ongoing criticism from animal rights organizations for not being cruelty-free. Kenvue conducts animal testing where required by law, particularly in China, leading to boycott campaigns from organizations like PETA and Cruelty Free Kitty. This controversy conflicts with Neutrogena's positioning as a health-conscious, dermatologist-recommended brand.
Product Safety Concerns: Beyond the benzene recall, Neutrogena has faced scrutiny over ingredient safety, particularly regarding active ingredients like salicylic acid and benzoyl peroxide that can cause skin irritation. Some consumers have reported adverse reactions to Neutrogena products, leading to debates about the balance between effective acne treatment and potential skin sensitivity.
Environmental Impact Criticism: Despite packaging sustainability initiatives, Neutrogena faces criticism for its environmental footprint, particularly regarding plastic packaging waste and chemical ingredients that may impact water systems. Environmental groups have called for greater transparency about ingredient sourcing and manufacturing processes.
Marketing and Efficacy Claims: Neutrogena has occasionally faced scrutiny over marketing claims, particularly regarding product effectiveness and dermatologist endorsements. Consumer advocates have questioned the extent of clinical testing backing certain marketing claims, leading to discussions about transparency in skincare advertising.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Walmart | USA | 2017 | Mass market | United states | All-ages | |
| Unilever | United Kingdom | 1957 | Mass market | Global | Womens | |
| Loreal | France | 1909 | Market leader | Global | All Genders | |
| Unilever | USA (Elida Beauty) | 1914 | Mass market | United states | Unisex | |
| Procter Gamble | USA | 1952 | Mass market | Global | Unisex | |
| Unilever | United Kingdom | 1846 | Mass market | Global | Womens |
Healthcare PharmaceuticalsOwned by Walmart Inc.
Walmart's private label personal care brand offering affordable everyday essentials including health, beauty, and wellness products.
Beauty Personal CareOwned by Unilever plc
Personal care brand owned by Unilever, known for beauty bars and skincare products. Over $5 billion in annual revenue.
Beauty Personal CareOwned by L'Oréal S.A.
L'Oréal Group flagship mass-market beauty brand, sold in over 150 countries. Skincare, haircare, makeup, and hair colour products.
Beauty Personal CareOwned by Unilever plc
American skincare brand founded in 1914 and known for its medicated deep cleansing cream. Owned by Elida Beauty, a Yellow Wood Partners portfolio company, since June 2024. Previously owned by Unilever (2010-2024), Alberto-Culver (2008-2010), and Procter & Gamble (1989-2008).
Beauty Personal CareOwned by Procter & Gamble Company
Mass-market skincare brand known for moisturizers and anti-aging products, owned by Procter and Gamble.
Beauty Personal CareOwned by Unilever plc
Global mass-market skincare brand owned by Unilever, founded in 1846 and known for cold cream, vanishing cream, and affordable skincare products sold in over 50 countries.
Market Positioning: Neutrogena competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Kenvue, giving you alternative choices that support different corporate structures.
Beauty Personal CareOwned by Evyap
Turkish beauty and bath soap brand manufactured by Evyap. Sold in over 100 countries. Known for natural ingredients including olive oil, shea butter, and coconut. Market leader in Eastern Europe and Central Asia.
Duru is privately owned, unlike Neutrogena which is under a publicly traded parent company.
Beauty Personal CareOwned by Evyap
Turkish brand of men's grooming and shaving products manufactured and marketed by Evyap, known for affordable quality shaving soaps.
Arko is privately owned, unlike Neutrogena which is under a publicly traded parent company.
Beauty Personal CareOwned by Nexus Capital Management
American direct-to-consumer razor and grooming brand known for its subscription model and viral marketing.
Dollar Shave Club is privately owned, unlike Neutrogena which is under a publicly traded parent company.
Beauty Personal CareOwned by Evyap
Mass-market soap and personal care brand owned by Evyap, sold in over 100 countries with strong positions in Eastern Europe and the Middle East.
Fax is privately owned, unlike Neutrogena which is under a publicly traded parent company.
Beauty Personal CareOwned by Evyap
Men's personal care and grooming brand owned by Evyap, a privately held Turkish personal care company founded in 1927. Gibbs offers shaving products, deodorants, and grooming items primarily in European, Middle Eastern, and Central Asian markets.
Gibbs is privately owned, unlike Neutrogena which is under a publicly traded parent company.
Beauty Personal CareOwned by Great Clips, Inc.
Value hair salon franchise brand owned by Great Clips, Inc. and operated through more than 4,400 franchisee-owned salons.
Great Clips is privately owned, unlike Neutrogena which is under a publicly traded parent company.
Discover popular brands and companies in the Beauty & Personal Care category and related searches from other users.

Italian luxury fragrance and grooming brand founded in Parma in 1916, owned by LVMH since 2001. Known for its signature Colonia fragrance and a full range of home and lifestyle products made in Italy.

Turkish antibacterial soap and personal hygiene brand owned by Evyap, one of Turkey's largest consumer goods manufacturers. Activex uses silver ion technology and is sold primarily in Turkey and Middle Eastern markets.

Procter & Gamble's feminine hygiene brand launched in 1983, holding approximately 27% global market share in menstrual pads and sold in more than 100 countries.